Under construction – not a live service
Sign in
CompletedNo phase

3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Status
Completed
People taking part
2 people enrolled
Started
18 Oct 2023
Ended
19 Jun 2025
Type of study
Interventional
Treatments tested
  • 3D Holographic Guidance, Navigation, and Control (3D GN&C)
Record updated
24 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • The patient meets the instructions for use (IFU) for the 24-28 mm body Cook Zenith Flex AAA bifurcated stent graft; Adequate iliac/femoral access compatible with the required introduction system; Non aneurysmal infrarenal aortic segment (neck) proximal to the aneurysm:; With a length of at least 15mm ii. With a diameter measured outer wall to outer wall of no greater than 26mm and no less than 20mm iii. With an angle less than 60 degrees relative to the long access of the aneurysm and iv. With an angle less than 45 degrees relative to the axis of the suprarenal aorta c. Iliac artery distal fixation site greater than 10mm in length and 7.5-20mm in diameter (measured outerwall to outerwall)
  • Male/female, aged ≥ 18
  • Patient fulfilling criteria for needing endovascular repair of abdominal aortic aneurysm according to routine clinical practice criteria of the participating center
  • Women of childbearing potential must be non-pregnant, non-lactating, and not planning to become pregnant during the course of the trial; and have a negative urine or serum pregnancy test within 7 days prior to index procedure
  • Provide written informed consent as applicable and defined by site country regulation
  • Stated willingness to comply with all study procedures and availability for the duration of the study

Who cannot take part

  • Presence of metallic implants above the knee, e.g., artificial hip
  • Current or planned participation in any other investigational drug or medical device clinical study that has not completed primary endpoint(s) evaluation
  • Other medical, social, or psychological issues that in the opinion of the investigator preclude the subjects from receiving this treatment, and the procedures and evaluations pre- and posttreatment
  • Contraindications for Cook Zenith Flex Aortic endograft:; Patients with known sensitivities or allergies to stainless steel, polyester, solder (tin, silver), polypropylene, or gold; Patients with a systemic infection who may be at increased risk of endovascular graft infection
  • Presence of electronic implants, e.g., cardiac pacemaker, automatic implantable cardioverter/defibrillator (AICD) or nerve stimulator
  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Patients not willing or able to give informed consent
  • Pregnant women
  • Patients' inability to have a contrasted CT scan
  • Anatomy outside of the IFU for a 24-28 mm Cook Zenith Flex AAA bifurcated stent graft

Where in United States

  • Cleveland ClinicCleveland, United StatesNo longer taking part

About the trial

What the trial wants to find out

This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft®.

The group in the trial

  • InterventionTreatment being tested

    Electromagnetic guidance and tracking as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft.

    Treatment: 3D Holographic Guidance, Navigation, and Control (3D GN&C)

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)
Record updated
24 April 2026